Scheie's Syndrome
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients (NCT00144768) | Genzyme, a Sanofi Company | 2004-07-01 |
Track Scheie's Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.